The neurobiology of APOE in schizophrenia and mood disorders
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
APOE is a major component of several lipoproteins. In addition to its role as a lipid transport protein APOE also serves a dual role as a glial derived, synaptic signalling molecule and thought to play an important role in synaptic plasticity and cognition. Polymorphisms within the APOE gene have been associated with the incidence of Alzheimer's disease. In light of the similarities in the cognitive deficits experienced in both Alzheimer's disease and schizophrenia as well as the comorbidity of depression in Alzheimer's disease, aberrant APOE signalling has been implicated in the pathologies of schizophrenia and mood disorders. The schizophrenia candidate gene, reelin, also shares common receptors with APOE, further supporting a role for APOE in the pathology of these disorders. This review will summarise the current understanding of the involvement of APOE and its receptors in the symptomatology and pathology of schizophrenia and mood disorders and the implications of this involvement for drug treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920 · cited 1×
“Most notably the APOE polymorphic variant, APOEε4 is associated with a dramatically increase in the risk of developing Alzheimer’s disease (AD) (7) and decreasing the age of onset (8), while allele APOEε2 is negatively associated with development of AD (9).”
BackgroundStress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
A protein related to extracellular matrix proteins deleted in the mouse mutant reeler
D'Arcangelo, G., G. Miao, G., Chen, S.-C., Scares, H. D., Morgan, J. I., & Curran, T. (1995) · Nature · doi:10.1038/374719a0 · Cited by 1,748 · cited 1×
“Embryologically, it is secreted from Cajal Retzius cells to guide neurons and radial glial cells to their correct positions (152-154), while in the adult brain it is secreted by GABAergic interneurons and is involved in neurotransmission, memory formation and modulating synaptic plasticity (155-157), making it a likel…”
BackgroundCNS synaptogenesis promoted by glia-derived cholesterol
Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711 · cited 2×
“Furthermore, in vitro studies have also shown that astrocyte-derived, cholesterol/APOE complexed lipoproteins promote synaptogenesis in purified neurons and that blocking APOE receptors reduced the synaptic activity induced by this lipoprotein complex (62).”
BackgroundHashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938 · cited 1×
“Several genes have been implicated in this disorder, including those involved in glutamatergic neurotransmission (92-94), regulation of presynaptic function (92, 95) G-protein signalling, (92, 96), GABAergic function (97), and synapse plasticity (98), however precise mechanisms underlying the pathophysiology are still…”
BackgroundMahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912
Ogawa, M., Miyata, T., Nakajimat, K., Yagyu, K., Seike, M., Ikenaka, K., Yamamoto, H., & Mikoshibat, K. (1995) · Neuron · doi:10.1016/0896-6273(95)90329-1 · Cited by 889 · cited 1×
“Embryologically, it is secreted from Cajal Retzius cells to guide neurons and radial glial cells to their correct positions (152-154), while in the adult brain it is secreted by GABAergic interneurons and is involved in neurotransmission, memory formation and modulating synaptic plasticity (155-157), making it a likel…”
BackgroundMirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P. (2000) · Neuron · doi:10.1016/s0896-6273(00)00085-4 · Cited by 882 · cited 1×
“Several genes have been implicated in this disorder, including those involved in glutamatergic neurotransmission (92-94), regulation of presynaptic function (92, 95) G-protein signalling, (92, 96), GABAergic function (97), and synapse plasticity (98), however precise mechanisms underlying the pathophysiology are still…”
BackgroundBoyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829
Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review
Eichner, J. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.6.487 · Cited by 796 · cited 1×
“(45, 46) and acting to both promote and prevent abnormalities in lipid metabolism.”
BackgroundHuman apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741 · cited 1×
“The APOE gene encodes a 317 amino acid peptide, from which an 18 signal peptide is cleaved to produce a 34kDa active peptide (12).”
BackgroundWeisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning
Weeber, E. J., Beffert, U., Jones, C., Christian, J. M., Förster, E., Sweatt, J. D., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205147200 · Cited by 623 · cited 1×
“an important role in neurotransmission within the tripartite synaptic complex (60, 61).”
BackgroundSullivan, P. M., Mezdour, H., Aratani, Y., Knouff, C., Najib, J., Reddick, R. L., Quarfordt, S. H., & Maeda, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.17972 · Cited by 575 · cited 1×
“Such studies have involved the administration of human recombinant APOE isoforms to APOE-deficient mice or the use of targeted replacement, APOE isoform-expressing mice (APOE-TR) which express one of the three human APOE isoforms under the control of an endogenous murine promoter (71).”
BackgroundReelin promoter hypermethylation in schizophrenia
Grayson, D. R., Jia, X., Chen, Y., Sharma, R. P., Mitchell, C. P., Guidotti, A., & Costa, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503736102 · Cited by 553
Reelin, lipoprotein receptors and synaptic plasticity
Herz, J., & Chen, Y. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2009 · Cited by 524
Electron microscopy of oligodendroglia in severe mental illness
Uranova, N., Orlovskaya, D., Vikhreva, O., Zimina, I., Kolomeets, N., Vostrikov, V., & Rachmanova, V. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00528-7 · Cited by 495
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., & Levitt, P. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000866 · Cited by 446 · cited 1×
“Several genes have been implicated in this disorder, including those involved in glutamatergic neurotransmission (92-94), regulation of presynaptic function (92, 95) G-protein signalling, (92, 96), GABAergic function (97), and synapse plasticity (98), however precise mechanisms underlying the pathophysiology are still…”
BackgroundProposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes
Zannis, V. I., Breslow, J. L., Utermann, G., Mahley, R. W., Weisgraber, K. H., Havel, R. J., Goldstein, J. L., Brown, M. S., Schonfeld, G., Hazzard, W. R., et al. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38094-9 · Cited by 436
Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains
Torrey, E. F., Barci, B. M., Webster, M. J., Bartko, J. J., Meador-Woodruff, J. H., & Knable, M. B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.019 · Cited by 426
Human Apolipoprotein E Receptor 2
Kim, D.-H., Iijima, H., Goto, K., Sakai, J., Ishii, H., Kim, H.-J., Suzuki, H., Kondo, H., Saeki, S., & Yamamoto, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8373 · Cited by 384
Raber, J., Wong, D., Buttini, M., Orth, M., Bellosta, S., Pitas, R. E., Mahley, R. W., & Mucke, L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10914 · Cited by 364 · cited 1×
“These impairments were observed in mice that express APOE e4 in neurons (79, 80) or astrocytes (81).”
BackgroundAltar, C. A., Jurata, L. W., Charles, V., Lemire, A., Liu, P., Bukhman, Y., Young, T. A., Bullard, J., Yokoe, H., Webster, M. J., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.031 · Cited by 318 · cited 1×
“Several genes have been implicated in this disorder, including those involved in glutamatergic neurotransmission (92-94), regulation of presynaptic function (92, 95) G-protein signalling, (92, 96), GABAergic function (97), and synapse plasticity (98), however precise mechanisms underlying the pathophysiology are still…”
BackgroundBellosta, S., Nathan, B. P., Orth, M., Dong, L.-M., Mahley, R. W., & Pitas, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27063 · Cited by 313 · cited 1×
“Most notably, in vitro numerous studies have reported enhanced neurite outgrowth in response to APOE e3 expression, while APOE e4 has been shown to inhibit neurite outgrowth (20-22).”
BackgroundCurran, T., & D'Arcangelo, G. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00035-0 · Cited by 246
Apolipoprotein E and cognitive performance
Raber, J., Wong, D., Yu, G.-Q., Buttini, M., Mahley, R. W., Pitas, R. E., & Mucke, L. (2000) · Nature · doi:10.1038/35006165 · Cited by 237
Fagan, A. M., Bu, G., Sun, Y., Daugherty, A., & Holtzman, D. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.30121 · Cited by 226
Lalazar, A., Weisgraber, K. H., Rall, S. C., Giladi, H., Innerarity, T. L., Levanon, A. Z., Boyles, J. K., Amit, B., Gorecki, M., & Mahley, R. W. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68957-4 · Cited by 209
Han, S.-H., Einstein, G., Weisgraber, K. H., Strittmatter, W. J., Saunders, A. M., Pericak-Vance, M., Roses, A. D., & Schmechel, D. E. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00013 · Cited by 195
Smalheiser, N. R., Costa, E., Guidotti, A., Impagnatiello, F., Auta, J., Lacor, P., Kriho, V., & Pappas, G. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1281 · Cited by 158 · cited 1×
“Taken together with mouse studies that show reduced reelin expression results in behavioral and anatomical abnormalities, such as deficits in prepulse inhibition and sensory gating, reduced neuropil density and reduced dedritic spine density in cortical pyramidal neurons, similar to those seen in patients with schizop…”
ResultGrootendorst, J., Bour, A., Vogel, E., Kelche, C., Sullivan, P. M., Dodart, J.-C., Bales, K., & Mathis, C. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.09.019 · Cited by 148
Rall, S. C., Weisgraber, K. H., Innerarity, T. L., Bersot, T. P., Mahley, R. W., & Blum, C. B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111085 · Cited by 141
Multiple pathways of apolipoprotein E signaling in primary neurons
Hoe, H., Harris, D. C., & Rebeck, G. W. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.03007.x · Cited by 111
Bartzokis, G., Lu, P. H., Geschwind, D. H., Tingus, K., Huang, D., Mendez, M. F., Edwards, N., & Mintz, J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.024 · Cited by 109
de Knijff, P., van den Maagdenberg, A. M., Stalenhoef, A. F., Leuven, J. A., Demacker, P. N., Kuyt, L. P., Frants, R. R., & Havekes, L. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115349 · Cited by 100
ApoE isoform-dependent changes in hippocampal synaptic function
Korwek, K. M., Trotter, J. H., LaDu, M. J., Sullivan, P. M., & Weeber, E. J. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-21 · Cited by 89 · cited 2×
“966 in the hippocampal CA1 region of the APOE knockout mouse, while APOE e2 decreases LTP induction and APOE e3 does not appear to alter LTP induction (3).”
BackgroundDifferential Binding of Apolipoprotein E Isoforms to Tau and Other Cytoskeletal Proteins
Fleming, L. M., Weisgraber, K. H., Strittmatter, W. J., Troncoso, J. C., & Johnson, G. V. W. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0064 · Cited by 82 · cited 2×
“Psychiatry Res 158(1), 75-78 (2008) 183.”
BackgroundKitamura, H. W., Hamanaka, H., Watanabe, M., Wada, K., Yamazaki, C., Fujita, S. C., Manabe, T., & Nukina, N. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.07.084 · Cited by 35 · cited 1×
“Thus, while young APOE e4TR mice display increased LTP these effects are not discernable in older animals, which may have implications for the pregression of cognitive deficits in psychiatric disorders.(75).”
BackgroundEffects of apoE on neuronal signaling and APP processing in rodent brain
Hoe, H.-S., Pocivavsek, A., Dai, H., Chakraborty, G., Harris, D. C., & Rebeck, G. W. (2006) · Brain Research · doi:10.1016/j.brainres.2006.07.035 · Cited by 30 · cited 1×
“Interestingly, in primary neuronal cell culture, the APOE-mediated reduction in JNK1/2 phosphorylation required activity of α-secretase (69, 70).”
BackgroundArnsten, A. F. T., & Goldman-Rakic, P. S. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.4.362 · Cited by 6
Cited by
Fusar‐Poli, P., Cappucciati, M., Rutigliano, G., Schultze‐Lutter, F., Bonoldi, I., Borgwardt, S., Riecher‐Rössler, A., Addington, J., Perkins, D., Woods, S. W., et al. (2015) · World Psychiatry · doi:10.1002/wps.20250 · Cited by 234
Common Variants in Psychiatric Risk Genes Predict Brain Structure at Birth
Knickmeyer, R. C., Wang, J., Zhu, H., Geng, X., Woolson, S., Hamer, R. M., Konneker, T., Lin, W., Styner, M., & Gilmore, J. H. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhs401 · Cited by 149
Li, W., Ban, C., Yue, L., Sun, L., Li, X., & Xiao, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00642 · Cited by 5
“(24) have pointed out that alterations in APOE expression might lead to either the risk of developing schizophrenia or clinical manifestations, as APOE was important in CNS functions such as modulating cell signaling, protein phosphorylation, intraneuronal calcium, and storage-induced synaptic sprouting.”
Background
Metadata
- Authors
- Gibbons, A. S.
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 2011
- Volume
- 16
- Issue
- 1
- Pages
- 962
- ISSN
- 1093-4715 (ISSN-L)
- 1093-9946
- DOI
- 10.2741/3729
- OpenAlex
- W1983545630
- Cited by
- 35
- References
- 40
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.